FoggyIsle.XYZ | Market's view on Angle

Stock watchers express concerns about the potential dilution of shares due to an imminent cash raise, estimating a possible price of 10p per share.
Doubts are raised regarding the possibility of a company takeover, with opinions that if a takeover were likely, it would have happened already.
There is speculation about the suitability of the company being sold to a larger player in the NGS or ctDNA liquid biopsy sectors rather than to individual companies like AZ.
Discussions highlight that a deal with AZ is seen merely as contract research and does not justify the recent rise in share price, suggesting other factors must be influencing the increase.
Concerns are voiced over the company’s need for another cash placement and the timeline for commercialisation, highlighting the risk of competitors reaching milestones first.
It is noted that if the company could materially increase its share price, it might be able to secure funding for a longer period without immediate financial concerns.
Some watchers are selling their shares in anticipation of potential bad news, like disappointing results or the announcement of a placing.
There is frustration over the management’s communication, particularly in relation to sales forecasts and financial sustainability, with the potential need for fundraising flagged as a significant concern.
The sentiment that the market or city doesn’t care about the specifics of the company’s actions unless they can maximise gains, suggesting that any fundraising might be met with significant dilution.
Overall, there is a mixed sentiment with some recognising the company’s potential, while others are cautious about its financial stability and the impact of upcoming results and possible fundraising efforts.